Liver-targeted hydrodynamic gene therapy: Recent advances in the technique

One of the major research focuses in the field of gene therapy is the development of clinically applicable, safe, and effective gene-delivery methods. Since the first case of human gene therapy was performed in 1990, a number of gene-delivery methods have been developed, evaluated for efficacy and s...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 22; no. 40; pp. 8862 - 8868
Main Authors Yokoo, Takeshi, Kamimura, Kenya, Abe, Hiroyuki, Kobayashi, Yuji, Kanefuji, Tsutomu, Ogawa, Kohei, Goto, Ryo, Oda, Masafumi, Suda, Takeshi, Terai, Shuji
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 28.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:One of the major research focuses in the field of gene therapy is the development of clinically applicable, safe, and effective gene-delivery methods. Since the first case of human gene therapy was performed in 1990, a number of gene-delivery methods have been developed, evaluated for efficacy and safety, and modified for human application. To date, viral-vectormediated deliveries have shown effective therapeutic results. However, the risk of lethal immune response and carcinogenesis have been reported, and it is still controversial to be applied as a standard therapeutic option. On the other hand, delivery methods for nonviral vector systems have been developed, extensively studied, and utilized in in vivo gene-transfer studies. Compared to viral-vector mediated gene transfer, nonviral systems have less risk of biological reactions. However, the lower gene-transfer efficiency was a critical hurdle for applying them to human gene therapy. Among a number of nonviral vector systems, our studies focus on hydrodynamic gene delivery to utilize physical force to deliver naked DNA into the cells in the living animals. This method achieves a high gene-transfer level by DNA solution injections into the tail vein of rodents, especially in the liver. With the development of genome editing methods, in vivo gene-transfer therapy using this method is currently the focus in this research field. This review explains the method principle, efficiency, safety, and procedural modifications to achieve a high level of reproducibility in large-animal models.
Bibliography:Takeshi Yokoo;Kenya Kamimura;Hiroyuki Abe;Yuji Kobayashi;Tsutomu Kanefuji;Kohei Ogawa;Ryo Goto;Masafumi Oda;Takeshi Suda;Shuji Terai;Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University;Institute for Research Collaboration and Promotion, Niigata University
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Supported by in part Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Sciences, No. 26860354 to Kamimura K, No. 16K19333 to Yokoo T, and No. 26293175 to Terai S.
Correspondence to: Kenya Kamimura, MD, PhD, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachido-ri, Chuo-ku, Niigata 951-8510, Japan. kenya-k@med.niigata-u.ac.jp
Telephone: +81-25-2272207 Fax: +81-25-2270776
Author contributions: Yokoo T, Kamimura K, Abe H, Kobayashi Y, Kanefuji T, Ogawa K, Goto R, Oda M, Suda T and Terai S all contributed to this paper.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v22.i40.8862